Burundi vs Cape Verde: Access to anti-retroviral drugs, female
Burundi
98.0%
in 2024
Cape Verde
98.0%
in 2024
Burundi rank
1st
Cape Verde rank
1st
Access to anti-retroviral drugs, female over time
- Burundi
- Cape Verde
How they compare
Burundi currently reports 98.0% against 98.0% in Cape Verde, a difference of 0.0%.
The two have swapped places 8 times across 25 shared years of data; in 2000 it was Cape Verde ahead.
Burundi ranks 1st and Cape Verde ranks 1st of 141 countries.
Cape Verde has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burundi | Cape Verde | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.0% | 9.9% | 2.9% | Cape Verde |
| 2010s | 56.2% | 59.5% | 3.3% | Cape Verde |
| 2020s | 95.6% | 96.6% | 1.0% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Burundi or Cape Verde?
- Burundi, at 98.0% against 98.0% in Cape Verde as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Burundi and Cape Verde?
- 0.0%, with Burundi ahead.
- How many years of comparable data are there for Burundi and Cape Verde?
- 25 years are reported by both, from 2000 to 2024.
- How do Burundi and Cape Verde rank globally for access to anti-retroviral drugs, female?
- Burundi ranks 1st and Cape Verde ranks 1st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.